Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
publication 23 March 2012 Molecular epidemiology of carbapenem - non - susceptible Acinetobacter baumannii in Japan 1 2 2 2 1 3 Shiro Endo *, Hisakazu Yano , Yoichi Hirakata , Kazuaki Arai , Hajime Kanamori , Miho ...
ObjectivesWe have investigated the molecular epidemiology and distribution of carbapenemase genes in 492 imipenem- non - susceptible Acinetobacter baumannii worldwide isolates (North and Latin America ...
. Carbapenem resistance in this organism is disheartening, further clouded by the emergence of colistin resistance.AimThe present prospective study aims to note the epidemiology , molecular profile, and clinical ...
, and meropenem, respectively. Carbapenem -resistance was 56.4% (22/39) among Acinetobacter species. Moreover, 92% (12/13) of Pseudomonas species non - susceptible to ceftazidime and/or meropenem, and 89.4% (17/19 ...
with non -baumannii Acinetobacter spp. (46.7% vs. 8.3%, P ...
, Kreiswirth B, Eisner W, Mariano N. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994; 12:1329-32.4. Roberts SA, Findlay R, Lang SDR ...
Background: Carbapenem -resistant Acinetobacter baumannii (CRAB) have been a challenging concern of health-care associated infections. The aim of the current study was to investigate the molecular ...
ABSTRACT The molecular epidemiology and carbapenem resistance mechanisms of clinical isolates of Acinetobacter baumannii obtained from a south Indian tertiary care hospital were investigated ...
epidemiology and carbapenem resistance mechanisms of A. baumannii in Tripoli, Northern Lebanon. Methods: One hundred sixteen non -duplicate isolates isolated between 2011 and 2013 in different hospitals ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!